35th generic medicines tender (antibiotics)

Summary

The tender concerns the conclusion of generic drug rebate agreements with pharmaceutical companies for substance-specific lots. The bidder must be prepared to supply finished medicinal products under a framework agreement and to submit the bid in line with the tender documents. The lots are divided by active substance, and e-invoicing is required for contract performance.